Rami Epstein

Rami Epstein serves as Chief Executive Officer at Kadimastem Ltd.. Kadimastem Ltd. operates in the research sector with approximately 32.0 employees. Kadimastem Ltd. generates annual revenue of 2800000.0.

Industry & Role Insights

• • MessageCEO tracks 2,961 executives in the research sector.
• • We have verified contacts for 2 executives at Kadimastem Ltd..
• • Our database includes 201,469 c suite-level executives.

Outlook Google Cloud Hosting Varnish Wix Mobile Friendly Shutterstock

stem cells drug screening for myelin sheath human oligodendrocytes human beta cells biobanking cell therapy gmp facilities cell production type 1 diabetes als alstreatment diabetescure clinicaltrials biotechnology research regenerative medicine disease treatment neurology diabetes human embryonic stem cells clinical trials biotechnology neurodegenerative diseases insulin-producing cells medical research fda approval treatment protocols cell differentiation pluripotent cells biopharmaceuticals off-the-shelf product gmp guidelines islet transplantation safety trials scientific publications innovation multi-target approach patient care healthcare technology industrial production metabolic diseases immune modulation cure for diabetes biomedical research blockbuster drug market applications biotech industry drug development treatment efficacy therapeutic cells biotech collaborations medical ethics clinical applications pharmaceutical production disease management cell-derived therapies partner collaborations technology transfer healthcare innovation biotechnology advancements medical diagnostics medical health care health wellness & fitness hospital & health care

AS

Asaf Shiloni Chief Executive Officer at Kadimastem Ltd.

SN

Srikanth Nandiraju Chief Technology Officer at 1Cell.Ai Inc.

SD

Surinnder Dang Chief Business Officer at 1Cell.Ai Inc.

M

Mark Chief Executive Officer at 23Strands

IT

Ilia Tikhomirov Chief Executive Officer at 35Pharma

Outreach Guidance — research Sector

Executives like Rami Epstein in the research sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Kadimastem Ltd..

Rami Epstein's Position in the MessageCEO Database

• •Rami Epstein is 1 of 2 verified executive contacts we track at Kadimastem Ltd..
• •2,871 verified executive contacts in research are in the MessageCEO database.
• •42 verified contacts work at research companies in the 32.0 employee range (same size as Kadimastem Ltd.).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated July 2026.

How do I reach Rami Epstein directly?

Rami Epstein's verified email address is available to MessageCEO Pro subscribers. They currently serve as Chief Executive Officer at Kadimastem Ltd.. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Rami Epstein work for?

Rami Epstein is Chief Executive Officer at Kadimastem Ltd., a company in the research sector with 32.0 employees.

Can I pitch or sell to Rami Epstein?

As Chief Executive Officer at Kadimastem Ltd., Rami Epstein is a key decision-maker in the research sector. MessageCEO Pro gives you verified email to reach Rami Epstein directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Rami Epstein in?

Rami Epstein works in the research industry as Chief Executive Officer at Kadimastem Ltd.. MessageCEO provides verified contact information for executives across all major industries.

Is Rami Epstein's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Rami Epstein's profile is kept up-to-date with the latest available information.

Last updated: July 18, 2026